Efficacy of Dolutegravir based single tablet regimen in people with HIV who inject drugs

AUTHORS

E. Alvarez1, W. Tinago1, S. Savinelli2, A.G. Cotter3, T. McGinty3, E. Muldoon3, E. Feeney2, J.S. Lambert3, P. McGettrick1, G. McCarthy4, J.M. Llibre5, P. Doran6, P.W. Mallon1


INSTITUTIONS

1University College Dublin, Centre for Experimental Pathogen Host Research, Dublin, Ireland, 2St. Vincent’s University Hospital, Department of Infectious Diseases, Dublin, Ireland, 3Mater Misercordiae University Hospital, Department of Infectious Diseases, Dublin, Ireland, 4Mater Misercordiae University Hospital, Department of Rheumatology, Dublin, Ireland, 5University Hospital Germans Trias i Pujol, Department of Infectious Diseases, Barcelona, Spain, 6University College Dublin, School of Medicine, Dublin, Ireland
25 July 2024
English
Download e-poster

Presenter

Stefano Savinelli